JLB & Associates’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1M | Sell |
|
|||||
|
2025
Q1 | $15.2M | Buy |
|
|||||
|
2024
Q4 | $18.4M | Buy |
|
|||||
|
2024
Q3 | $25.4M | Sell |
|
|||||
|
2024
Q2 | $31.5M | Sell |
|
|||||
|
2024
Q1 | $29.4M | Sell |
|
|||||
|
2023
Q4 | $26M | Sell |
|
|||||
|
2023
Q3 | $24.6M | Sell |
|
|||||
|
2023
Q2 | $22.8M | Sell |
|
|||||
|
2023
Q1 | $23.4M | Sell |
|
|||||
|
2022
Q4 | $20.2M | Sell |
|
|||||
|
2022
Q3 | $15.3M | Sell |
|
|||||
|
2022
Q2 | $17.3M | Sell |
|
|||||
|
2022
Q1 | $17.5M | Buy |
|
|||||
|
2021
Q4 | $17.6M | Sell |
|
|||||
|
2021
Q3 | $15.2M | Sell |
|
|||||
|
2021
Q2 | $13.7M | Buy |
|
|||||
|
2021
Q1 | $10.6M | Buy |
|
|||||
|
2020
Q4 | $10.9M | Buy |
|
|||||
|
2020
Q3 | $10.7M | Buy |
|
|||||
|
2020
Q2 | $10M | Sell |
|
|||||
|
2020
Q1 | $9.3M | Sell |
|
|||||
|
2019
Q4 | $9.32M | Sell |
|
|||||
|
2019
Q3 | $8.44M | Buy |
|
|||||
|
2019
Q2 | $8.1M | Buy |
|
|||||
|
2019
Q1 | $8.23M | Buy |
|
|||||
|
2018
Q4 | $7.24M | Sell |
|
|||||
|
2018
Q3 | $7.75M | Buy |
|
|||||
|
2018
Q2 | $7.52M | Buy |
|
|||||
|
2018
Q1 | $7.15M | Buy |
|
|||||
|
2017
Q4 | $6.99M | Buy |
|
|||||
|
2017
Q3 | $5.45M | Buy |
|
|||||
|
2017
Q2 | $4.81M | Buy |
|
|||||
|
2016
Q4 | $4.33M | Buy |
|
|||||
|
2016
Q3 | $4.92M | Buy |
|
|||||
|
2016
Q2 | $5.89M | Sell |
|
|||||
|
2016
Q1 | $4.21M | Buy |
|
|||||
|
2015
Q4 | $5.61M | Buy |
|
|||||
|
2015
Q3 | $5.08M | Buy |
|
|||||
|
2015
Q2 | $5.07M | Sell |
|
|||||
|
2015
Q1 | $4.95M | Buy |
|
|||||
|
2014
Q4 | $3.8M | Buy |
|
|||||
|
2014
Q3 | $4.26M | Sell |
|
|||||
|
2014
Q2 | $4.16M | Buy |
|
|||||
|
2014
Q1 | $3.94M | Buy |
|
|||||
|
2013
Q4 | $3.1M | Buy |
|
|||||
|
2013
Q3 | $2.69M | Buy |
|
|||||
|
2013
Q2 | $2.36M | Buy |
|